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Abstract
Purpose Fluorine-18-fluorodeoxyglucose (18F-FDG) posi-
tron emission tomography (PET) and diffusion-weighted
magnetic resonance imaging (DWI) share the same role in
clinical oncology and it is feasible to obtain the standardized
uptake value (SUV) and apparent diffusion coefficient (ADC)
simultaneously by emerging the hybrid positron emission
tomography/magnetic resonance (PET/MR). This study in-
vestigated the correlation between the ADCs of rectal cancer
lesions and their SUVs derived from hybrid PET/MR.
Methods Nine patients with histologically proven rectal ade-
nocarcinoma (5 men, 4 women; mean age, 70±15.91 years)
underwent torso 18F-FDG PET/CT and regional hybrid 18F-
FDG PET/MR sequentially. A fixed threshold value of 40 %
of maximum uptake was used to determine tumor volume of
interest (VOI) on PET image; SUVmax, SUVpeak, and
SUVmean were calculated automatically. A single freehand
region of interest (ROI) was drawn on high b-value (b1000)
DWI image and copied to corresponding ADC map to deter-
mine the ADCmean of rectal cancer lesion. Spearman’s rank
correlation coefficient (ρ) was calculated to determine the cor-
relation between SUVs and ADC values.
Results SUVmax, SUVpeak, and SUVmean derived by hy-
brid PET/MR were 12.35±4.66 (mean± standard deviation),
9.66±3.15 and 7.41±2.54, respectively. The ADCmean val-
ue of rectal cancer lesions was 1.02 ± 0.08 × 10−3mm2/s.
ADCmean was significantly and inversely correlated with
SUV values (SUVmax, ρ = −0.95, p < 0.001; SUVpeak,
ρ=−0.93, p<0.001; SUVmean, ρ=−0.91, p=0.001).
Conclusions This preliminary hybrid PET/MR study demon-
strates a significant inverse correlation exists between meta-
bolic activity on 18F-FDG PETand water diffusion on DWI in
rectal cancer.
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Introduction
Organ sparing procedures are preferred for the management of
rectal cancer to retain sphincter, urinary, and sexual function
but organ sparing is not always possible. Thus neoadjuvant
therapies are currently favored for locally advanced rectal tu-
mors. Moreover preoperative and postoperative adjuvant ther-
apies provide benefits with respect to the control of local and
regional diseases [1, 2]. The decision to apply adjuvant ther-
apy has led to an increasing role of preoperative imaging mo-
dalities to select high-risk patients that could benefit from
more aggressive treatment.
In oncology, PET/CT imaging has been successfully
established as a clinical tool for tumor staging and for deter-
mining response to therapy [3]. 18F-FDG PET/CT provides
metabolic information on tumors, based on the assumption
that cancer cells generally have increased glucose utilization.
SUV is a semi-quantitative measure of tissue glucose utiliza-
tion in cancer and SUVmax has beenwidely used to quantitate
the metabolic activity of tumors. Recently, an integrated
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whole body PET/MR scanner was introduced, and is expected
to have potential value over that of PET/CT. Because MR data
provide high soft tissue contrast and can provide accurate
anatomical details. Furthermore, MR system can offer func-
tional information, such as perfusion, diffusion, spectroscopy,
and functional MR imaging, that would complement the met-
abolic information provided by PET [4]. In particular, DWI
represents the functional MR techniques and has been applied
in numerous cancers. DWI explores the random Brownian
motion of water molecules in tissues, which is more restricted
in tissues with high cellular densities, such as tumor tissues.
ADC, a quantitative value derived from DWI, may provide
information on biological characteristics such as tumor cellu-
larity, tumor aggressiveness, and response to cancer treatment
[5, 6] like PET SUV. In the present study, we investigated the
correlation between the SUVand ADC values of rectal cancer
lesions using hybrid 18F-FDG PET/MR to minimize the po-
tential for physiologic changes and misregistration associated
with separate PET and MR acquisitions.
Materials and Methods
Subjects
The study subjects were nine consecutive patients (5 men, 4
women; mean age, 70±15.91 years) with newly diagnosed
and pathologically confirmed rectal adenocarcinoma that
underwent the torso 18F-FDG PET/CT, immediately followed
by regional hybrid PET/MR (no additional 18F-FDG injec-
tion) at our institution from February 2013 to July 2013.
Patients that received neoadjuvant chemotherapy or radiation
therapy were excluded. Written informed consent was obtain-
ed from all patients.
Image Acquisition
All patients fasted for at least 6 hours before the admin-
istration of 18F-FDG and blood glucose concentrations
were confirmed to be less than 150 mg/dl. Patients re-
ceived an intravenous injection of 382.91 ± 65.06 MBq
of 18F-FDG and acquis i t ion was s tar ted 77.56
± 10.79 minutes la te r us ing a PET/CT scanner
(Discovery VCT, GE Healthcare, Milwaukee, Wis.,
USA) containing bismuth germinate (BGO) crystals for
PET and 64-detector row CT. Initially, a CT scan from
skull base to upper thighs was obtained for attenuation
correction (AC) of PET/CT images. CT parameters were
as follows: 120 kV-200 mA, 3.75 mm slice thickness,
2.5 mm reconstruction thickness, and 512 × 512 matrix.
A 3D mode PET scan was then performed with 7–9 bed
positions at 3 minutes per bed position. The PET/CT PET
scanner had an average spatial resolution of 5.0 mm at
1 cm and 5.6 mm at 10 cm from the transverse field of
view (FOV) and a maximum sensitivity of 8.5 kcps/MBq
at the center of the FOV.
Subsequent to obtaining torso PET/CT data, hybrid PET/
MR (Biograph mMR, Siemens Healthcare, Erlangen,
Germany) was performed (113.44 ± 16.51 minutes after
injecting 18F-FDG) covering 1 bed position of the pelvis with
a body surface coil (TIM, Siemens Healthcare, Erlangen,
Germany). The hybrid PET/MR scanner consisted of a 3-
Tesla MRI scanner with high gradient performance (maxi-
mum amplitude, 45 mT/m; maximum slew rate, 200 T/m/s)
and an inline PET system with an avalanche photodiode
(APD) detector. The PET scanner of the PET/MR containing
lutetium oxyorthosilicate (LSO) crystals has a spatial resolu-
tion of 4.4 mm at 1 cm and of 5.2 mm at 10 cm from the
transverse FOV and a sensitivity of 13.2 kcps/MBq at the
center of the FOV. The PET scan was obtained for 7 minutes
and MR imaging was performed simultaneously using the
following sequence protocol:
1. A coronal 3D volume interpolated breath-hold examina-
tion (VIBE) T1-weighted MR sequence (repetition time
(TR) 3.6 ms, echo time 1 (TE1) 1.23 ms, TE2 2.46 ms,
3.12 mm slice thickness, 4.10×2.60 mm in-plane resolu-
tion, 172×172 matrix, FOV 500 mm, generalized auto
calibrating partially parallel acquisition (GRAPPA); ac-
celeration factor 2, protocol time 19 seconds) for Dixon-
based AC;
2. A coronal 3D T2-weighted Sampling Perfection with
Application optimized Contrasts using different flip angle
Evolutions (SPACE) (TR 1400 ms, TE 109 ms, 1 mm
slice thickness, 0.98 × 0.99 mm in-plane resolution,
389×384 matrix, FOV 380 mm, GRAPPA acceleration
factor 3, protocol time 7 minutes 11 seconds);
3. A transverse single-shot spin echo echo planar imaging
(EPI) DWI with free-breathing (TR 7800 ms, TE 85 ms,
b-values 0, and 1000 s/mm2, 3 mm slice thickness,
1.95 × 1.56 mm in-plane resolution, 115 × 160 matrix,
FOV 250 mm, GRAPPA acceleration factor 2, protocol
time 3 minutes 31 seconds).
A 3D ordered-subsets expectation maximization (OSEM)
iterative reconstruction algorithm was applied with two itera-
tions and 28 subsets for PET/CT PET data and with two iter-
ations and 21 subsets for PET/MR PET data. For PET/CTand
PET/MR 128×128 and 172×172 matrices were used, respec-
tively, and in both cases PET data were filtered (6 mm full
width at half maximum).
Image Analysis
Two experienced nuclear medicine physicians interpreted
PET/CT and hybrid PET/MR images using a dedicated
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workstation and Syngo.via software (Siemens Healthcare,
Erlangen, Germany). These two readers analyzed PET/CT
and PET/MR images unaware of the results of other tests
and clinical information. Diagnoses were made by con-
sensus. The maximum, peak, and mean SUVs of all rectal
tumors were assessed for quantitative comparison on the
PET images of both modalities. A VOI was placed over a
FDG avid rectal tumor on the PET images, and an iso-
contour VOI including all voxels above 40 % of maxi-
mum was then created and SUVmax, SUVpeak, and
SUVmean values were calculated automatically. For
ADC measurements, a polygonal ROI was manually
drawn along the border of the tumor on the high b-value
(b 1000) DWI image. A single freehand ROI was drawn
on the single slice containing the largest tumor area and
copied to the corresponding ADC map (Fig. 1). ADC
maps in grayscale were automatically generated by the
operating system using a mono-exponential decay model.
ADCmean values were evaluated for all rectal cancer
lesions.
Statistics
The statistical analysis was performed using SPSS 21.0 soft-
ware (SPSS, Chicago, Ill., USA). The Wilcoxon signed ranks
test was used to determine the significances of differences
between SUVs measured using the two imaging modalities.
P values of < 0.05 were considered statistically significant.
Spearman’s rank correlation coefficient (ρ) was calculated to
examine the correlation between maximum, peak, and mean
SUVs derived from regional hybrid PET/MR and torso PET/
CT. We also evaluated the correlation between SUVand ADC
values using Spearman’s rank correlation.
Results
For the nine rectal cancer lesions, mean SUVmax, SUVpeak,
and SUVmean values obtained by hybrid PET/MR were
12.35±4.66, 9.66±3.15 and 7.41±2.54, respectively. SUVs
measured by hybrid PET/MR were significantly lower
(SUVmax, p = 0.01; SUVpeak, p = 0.02; SUVmean,
p = 0.01) than SUVs determined by torso PET/CT
(SUVmax, 18.96 ± 10.93; SUVpeak, 13.85 ± 8.05;
SUVmean, 11.03± 6.13). However, quantitative evaluation
of PET images revealed a high correlation between maximum,
peak, and mean SUVs obtained using the two modalities
(SUVmax, ρ = 0.82, p = 0.007; SUVpeak, ρ = 0.93,
p<0.001; SUVmean, ρ=0.77, p=0.016) (Fig. 2).
Mean ADCmean value of cancer lesions was 1.02
±0.08×10−3mm2/s. Hybrid PET/MR data showed a strong
inverse correlation between ADCmean and SUV values
(SUVmax, ρ = −0.95, p < 0.001; SUVpeak, ρ = −0.93,
p<0.001; SUVmean, ρ=−0.91, p=0.001) (Figs. 3 and 4).
The ADCmean values of hybrid PET/MR showed a signifi-
cant inverse correlation with SUVmax (ρ=−0.75, p=0.021),
SUVpeak (ρ=−0.80, p =0.010), and SUVmean (ρ=−0.69,
p=0.041) assessed by PET/CT.
Fig. 1 An 82-year-old man with
rectal adenocarcinoma. Axial T2-
weighted SPACE image (a),
fused 18 F-FDG PET and axial
T2-weighted SPACE images (b),
b1000 diffusion image (c), and
ADC map (d) all acquired by
hybrid PET/MR. ADC value was
measured by drawing a freehand
ROI along the high signal
intensity tumor border on a single
slice b1000 image containing the
largest tumor area (c). The ROI
was copied to the ADCmap (d) to
calculate the ADCmean. ADC
map was automatically generated
in grayscale by the operating
system, using a mono-
exponential decay model
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Fig. 2 Correlation analyses of SUVmax (a), SUVpeak (b), and SUVmean (c) of rectal cancer lesions obtained by PET/CTand subsequent hybrid PET/
MR. High correlations were found between SUV values from two modalities. ρ= Spearman’s rank correlation coefficient
Fig. 3 A 58-year-old man with
rectal adenocarcinoma. Axial T2-
weighted SPACE image (a),
fused 18 F-FDG PET image and
axial T2-weighted SPACE image
(b) obtained by hybrid PET/MR
showing FDG avid rectal wall
thickening at the left lateral wall.
SUVmax, SUVpeak, and
SUVmean of the tumor were
8.14, 6.76, and 5.21, respectively.
DWI (c) depicted the tumor as a
high signal intensity lesion, and
the corresponding ADC map (d)
showed reduced ADC in the
tumor (ADCmean was
1.04 × 10−3 mm2/s)
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Discussion
Hybrid PET/MR presented significantly lower SUVs than tor-
so PET/CT for rectal cancer, which confirms recently pub-
lished results [7–9]. Several factors could explain this discrep-
ancy in SUVs. Basic technical difference, such as the AC
methods used by two modalities, is probably a major cause.
Whereas CT based AC in PET/CT is straightforward because
CT measures the attenuation coefficients of tissues at X-ray
energies, MR based AC in hybrid PET/MR is more complex
because the MR signal does not provide radiodensity infor-
mation. Hybrid PET/MR uses an attenuation map with a 4
tissue class segmentation (fat, soft tissue, lungs, and back-
ground/air) that is generated on the basis of a 2-point Dixon
MRI sequence [10]. Several potential pitfalls of MR based
AC, such as truncation artifacts resulting from insufficient
coverage of arms and trunk and ignorance of attenuation by
the bone, have been previously discussed [11] and these tech-
nical issues could cause discrepancy in SUV quantification.
Additionally, different scanner geometries, hardware, acquisi-
tion protocols, image reconstruction algorithms, and data an-
alyzing software are also potential technical factors. Tracer
clearance with time could also explain the SUV discrepancy
[9]. However, our data showed a strong correlation between
SUV values of rectal cancer lesions determined by hybrid
PET/MR and PET/CT (SUVmax, ρ = 0.82; SUVpeak,
ρ=0.93; SUVmean, ρ=0.77).
Although MR based AC is a work in progress, it is ex-
pected that hybrid PET/MR will offer further advantages
over PET/CT. A variety of functional information including
diffusion can be added to the metabolic information provid-
ed by PET as well as morphologic information. Furthermore,
simultaneous data acquisition enables real time multi-
parametric functional imaging. 18F-FDG PET images in-
creased glycolysis resulting from a specific metabolic abnor-
mality of cancer cells, which is known as the Warburg effect
[12]. It has been suggested that FDG uptake reflects tumor
grading and cellular proliferation because less differentiated
and more rapidly growing tumors probably metabolize more
glucose for energy production. DWI depicts water diffusion
in biologic tissue and the degree of restriction of this diffu-
sion is inversely related to tissue cellularity and cell mem-
brane integrity. Hence ADC is also considered a parameter
of tumor characteristics such as tumor cellularity, tumor ag-
gressiveness and cancer treatment response [5, 6]. Previous
studies have reported negative correlations between SUV
Fig. 4 Correlations between ADC and SUV values assessed by hybrid
PET/MR. Scatter plots showed the strong inverse correlations between
ADCmean and SUV values. ADCmean was found to be significantly and
negatively correlated with SUVmax (a), SUVpeak (b), and SUVmean (c)
by Spearman’s rank correlation analyses (SUVmax, ρ =−0.95, p < 0.001;
SUVpeak, ρ = −0.93, p < 0.001; SUVmean, ρ = −0.91, p = 0.001).
ρ =Spearman’s rank correlation coefficient
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and ADC in pancreatic cancer, non-small cell lung cancer,
head and neck squamous cell carcinoma, GIST, and rectal
cancer [13–18]. In the present study, hybrid PET/MR dem-
onstrated a strong inverse correlation between ADCmean
and SUV values (SUVmax, ρ = −0.95; SUVpeak,
ρ = −0.93; SUVmean, ρ = −0.91) in rectal cancer. The
ADCmean values of PET/MR were also found to be signif-
icantly and negatively correlated with SUVmax (ρ=−0.75),
SUVpeak (ρ=−0.80), and SUVmean (ρ=−0.69) values
assessed by PET/CT, although Spearman’s rank correlation
coefficients were smaller than for hybrid PET/MR. These
results are in agreement with previous reports on rectal can-
cer [17, 18] and with expectation, because SUV and ADC
values are directly related to tumor cellularity. Therefore, we
suggest the significant negative correlation found between
SUV and ADC probably represents a true biologic relation
between tumor cellularity and metabolic activity and that
these two parameters play a complementary role in terms
of describing tumor characteristics, assessing treatment re-
sponse, and planning treatment in rectal cancer.
SUVmax is relatively independent of tumor size and shape
because tumor is segmented by adaptive thresholding, and
thus, SUV measurements are rapid and highly reproducible.
In contrast ADC measurements are influenced by ROI size
and placement and by interobserver variability [19]. On the
other hand, the simultaneous acquisition of SUV and ADC
data without patient motion by hybrid PET/MR minimizes
biologic changes and misregistration artifacts, and probably
provides stronger negative correlations than were previously
obtained by separate modalities (PET/CT and MR) with an
interval of time.
Our study has some limitations. First, we assessed only
ADCmean values, which are generally accepted as a more
reliable indicator of tumor cellularity since the entire lesion
is taken into account. Although ADCmin had been suggested
to reflect highest tumor cell density or the most proliferative
portion of a tumor [18], the use of ADCmin is likely to result
in high errors due to the effects of lesion heterogeneity or
artifacts. For these reasons, we did not evaluate ADCmin
values in the present study. Second, we measured ADC value
on a single slice containing the largest available tumor area.
ADC measurements obtained using whole tumor volumes
were more reproducible than those obtained from single-
slice or small sample measurements in rectal cancer.
However, there was no significant difference between the tu-
mor ADCs obtained using whole-volume measurements and
the single-slice approach in the study of Lambregts et al. [19].
Thus, we chose the single-slice method because the whole-
volume ROIs protocol is time consuming and simpler, quicker
methods are preferred in clinical practice. Third, only a small
number of patients were included, and thus, our find should be
considered preliminary. Accordingly, further studies are need-
ed to confirm our results.
Conclusions
This hybrid PET/MR study demonstrates a significant nega-
tive correlation exists between metabolic activity on 18F-FDG
PET and water diffusion on DWI in rectal cancer, presumably
because both parameters are directly related to tumor cellular-
ity. The correlation found between SUVs and ADC values
supports the notion that high cellularity due to tumor prolifer-
ation results in greater metabolism activity and restricts water
diffusion. Further studies are needed to clarify the comple-
mentary roles of SUV and ADC with respect to the determi-
nation of tumor characteristics, the assessment of treatment
response, and the planning of treatment for rectal cancer.
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